B. Braun Medical Inc recalls Ceftazidime for Injection USP and Dextrose for Injection USP, 2 g, 50 mL Duplex Container, RX only, B Braun Medical Inc.
Recalled May 6, 2020 · FDA recall D-1257-2020 · B. Braun Medical
Hazard
Failed Stability Specifications: Out-of-Specification (OOS) results for High Molecular Weight Polymers. · FDA Class I
Units
22,488 Duplex containers
Sold at
Product was distributed nationwide within the United States.
Description
Failed Stability Specifications: Out-of-Specification (OOS) results for High Molecular Weight Polymers.
Product
Ceftazidime for Injection USP and Dextrose for Injection USP, 2 g, 50 mL Duplex Container, RX only, B Braun Medical Inc., Bethlehem, PA 18018-3524, NDC 0264-3145-11
Manufacturer(s)
B. Braun Medical Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →